A long action profile supports a single weekly subcutaneous injection , and a stepwise dose increase helps keep tolerability high while the body adjusts [3] [4]
Typically, only mild side effects are experienced, and they may include minor blistering, swelling, or redness
This datadriven, combination approach promises more precise sleep optimization, tissue repair, and healthspan extension
The results are mixed: some musculoskeletal studies show enhanced local healing with proximal injection, while others show comparable efficacy between subcutaneous and peri-lesional routes
Mechanistic studies to better understand the molecular targets and pathways involved in peptide action could help identify potential adverse effects and inform safer clinical use